MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
ClearPoint Neuro Operating Income 2011-2025 | CLPT
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income ClearPoint Neuro
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -19.7 M | -22.4 M | -16.3 M | -13.4 M | -6.22 M | -4.59 M | -5.25 M | -6.34 M | -7.49 M | -8.97 M | -5.32 M | -7.47 M | -3.13 M | -5.92 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -3.13 M | -22.4 M | -9.47 M |
Quarterly Operating Income ClearPoint Neuro
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.28 M | -5.68 M | -6.16 M | - | -5.16 M | -4.72 M | -4.22 M | - | -4.9 M | -7.13 M | -5.71 M | - | -3.8 M | -4.2 M | -3.86 M | - | -3.8 M | -3.41 M | -2.18 M | - | -1.27 M | -1.48 M | -1.21 M | - | -911 K | -1.29 M | -972 K | - | -1.21 M | -1.64 M | -1.43 M | - | -1.33 M | -1.82 M | -1.35 M | - | -1.71 M | -2.06 M | -1.93 M | - | -1.93 M | -2.68 M | -2.94 M | - | -2.62 M | -2.22 M | 2.19 M | - | -1.86 M | -2.18 M | -1.37 M | - | -1.02 M | -3.13 M | -1.15 M | - | -1.43 M | -1.47 M | -1.71 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.19 M | -7.13 M | -2.61 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apyx Medical Corporation
APYX
|
-17.3 M | $ 3.86 | -3.26 % | $ 134 M |  USA |
 |
BioSig Technologies
BSGM
|
-12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Abiomed
ABMD
|
230 M | - | - | $ 17.2 B | USA |
 |
Cutera
CUTR
|
-156 M | - | -10.19 % | $ 1.99 M | USA |
 |
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | USA |
 |
Bio-Rad Laboratories
BIO
|
269 M | $ 307.92 | -1.93 % | $ 8.69 B | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
Bruker Corporation
BRKR
|
253 M | $ 45.13 | -2.67 % | $ 6.72 K | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
Abbott Laboratories
ABT
|
6.82 B | $ 125.1 | 1.48 % | $ 218 B | USA |
 |
Boston Scientific Corporation
BSX
|
2.6 B | $ 92.34 | 0.64 % | $ 136 B | USA |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 2.56 | 8.94 % | $ 95.5 M |  France |
 |
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
IRIDEX Corporation
IRIX
|
-10 M | $ 0.92 | -4.72 % | $ 14.8 M | USA |
 |
IRadimed Corporation
IRMD
|
22 M | $ 96.35 | -1.06 % | $ 1.22 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-35 M | $ 17.7 | -3.46 % | $ 408 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
LivaNova PLC
LIVN
|
129 M | $ 62.79 | -1.82 % | $ 3.41 B |  Britain |
 |
Pulmonx Corporation
LUNG
|
-57.7 M | $ 2.53 | 0.86 % | $ 99 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
InMode Ltd.
INMD
|
113 M | $ 14.56 | 0.76 % | $ 1.15 B |  Israel |
 |
Cognyte Software Ltd.
CGNT
|
-5.13 M | $ 9.88 | 0.05 % | $ 709 M | Israel |
 |
Myomo
MYO
|
-10.7 M | $ 1.06 | -1.85 % | $ 7.47 M | USA |
 |
Second Sight Medical Products
EYES
|
-24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
28.4 M | $ 13.41 | -4.56 % | $ 1.03 B | USA |
 |
Align Technology
ALGN
|
608 M | $ 165.15 | 0.78 % | $ 12.4 B | USA |
 |
Accuray Incorporated
ARAY
|
7.84 M | $ 1.07 | -3.18 % | $ 110 M | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
Orthofix Medical
OFIX
|
-84.6 M | $ 15.51 | -1.27 % | $ 591 M |  Curacao |
 |
FONAR Corporation
FONR
|
5.31 M | $ 14.86 | -0.03 % | $ 97.4 M | USA |
 |
AxoGen
AXGN
|
-3.29 M | $ 30.33 | 1.15 % | $ 1.34 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | USA |
 |
CONMED Corporation
CNMD
|
200 M | $ 40.78 | 2.33 % | $ 1.26 B | USA |
|
LENSAR
LNSR
|
-10.7 M | $ 11.48 | -0.17 % | $ 132 M | USA |